CLINICAL_TRIALS
ClinicalTrials.gov record update
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease: MARINER
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05575037
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:18.201507+00:00
- Published At
- 2025-09-16T00:00:00+00:00
- Record Updated At
- 2025-09-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Nasal Polyps", "Asthma, Aspirin-Induced", "Aspirin-Exacerbated Respiratory Disease", "Aspirin-Sensitive Asthma With Nasal Polyps"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-16"- protocolSection.identificationModule.nctId
"NCT05575037"- protocolSection.identificationModule.officialTitle
"Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease: MARINER"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.